CLINICAL_TRIALS
trial_result
· 2014-12-18
Clinical Trial Update: Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) [Phase 3]
Summary
Phase 3 trial evaluating golimumab in adults with active axial spondyloarthritis, including ankylosing spondylitis; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Spondylitis, Ankylosing | Phase 3 | Status: COMPLETED | Results posted: 2014-12-18